Hemotune

Schlieren, Switzerland

Hemotune is a medical device company that develops a therapeutic blood purification platform for the treatment of health ailments.

$15.6M raised

Mar 2024

Series B

Top Investors

Zúrcher Kantonal BankVenture KickInnosuisseEASMEEIT Health

19,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Hemotune raised?

Hemotune has raised $15.6M in total funding. The most recent round was Series B. The last funding was announced in March 2024.

Who are Hemotune's investors?

Hemotune's investors include Zúrcher Kantonal Bank, Venture Kick, Innosuisse, EASME, EIT Health.

Where is Hemotune headquartered?

Hemotune is headquartered in Schlieren, Switzerland.

What does Hemotune do?

Hemotune is a medical device company that develops a therapeutic blood purification platform for the treatment of health ailments.

What stage is Hemotune at?

Hemotune is at the Series B stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated March 25, 2024.

MLA

"Hemotune — Funding & Investors." VCBacked, March 25, 2024, https://www.vcbacked.co/company/hemotune. Accessed June 3, 2026.

APA

VCBacked. (2024). Hemotune — Funding & Investors. Retrieved June 3, 2026, from https://www.vcbacked.co/company/hemotune

Wikipedia (cite web)

{{cite web |title=Hemotune — Funding & Investors |url=https://www.vcbacked.co/company/hemotune |website=VCBacked |access-date=June 3, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated March 25, 2024.